Katrine Bosley is CEO & President at Editas Medicine, Inc. (EDIT). They have made 22 open-market trades across 1 company since 2017, most recently 2019-01-08.
CIK 0001592469
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EDIT | 1,204,966 | $2.8M |
Shares reported on the most recent Form 4, priced at the 2019-01-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDIT | SELL | 2019-01-08 | 2019-01-10 | $25.27 | $303K | -23.4% | -23.9% | +5.5% |
| EDIT | SELL | 2018-12-03 | 2018-12-06 | $31.92 | $383K | -10.8% | -15.4% | -23.2% |
| EDIT | SELL | 2018-11-01 | 2018-11-05 | $26.88 | $323K | +0.9% | +6.7% | -21.2% |
| EDIT | SELL | 2018-10-01 | 2018-10-03 | $31.02 | $745K | -9.6% | -6.6% | -22.2% |
| EDIT | SELL | 2018-09-04 | 2018-09-06 | $32.31 | $736K | +9.7% | -6.9% | -0.8% |
| EDIT | SELL | 2018-08-20 | 2018-08-22 | $30.17 | $724K | +6.4% | -2.3% | -17.1% |
| EDIT | SELL | 2018-08-01 | 2018-08-03 | $29.47 | $429K | +0.2% | +13.1% | -5.3% |
| EDIT | SELL | 2018-07-02 | 2018-07-05 | $36.36 | $497K | -1.2% | -21.2% | -18.1% |
| EDIT | SELL | 2018-06-01 | 2018-06-05 | $37.39 | $544K | -2.6% | -4.3% | -14.8% |
| EDIT | SELL | 2018-05-01 | 2018-05-03 | $31.95 | $532K | +13.7% | +14.2% | -8.2% |
| EDIT | SELL | 2018-04-02 | 2018-04-04 | $32.04 | $422K | +1.4% | -2.9% | +8.3% |
| EDIT | SELL | 2018-03-09 | 2018-03-13 | $45.00 | $411K | -8.2% | -13.9% | -12.4% |
| EDIT | SELL | 2018-03-01 | 2018-03-05 | $35.53 | $358K | +0.9% | -13.4% | -6.2% |
| EDIT | SELL | 2018-02-01 | 2018-02-05 | $36.02 | $499K | +5.4% | +28.1% | +1.7% |
| EDIT | SELL | 2018-01-29 | 2018-01-31 | $38.79 | $776K | -9.1% | +5.0% | -10.1% |
| EDIT | SELL | 2018-01-23 | 2018-01-25 | $35.28 | $236K | +1.2% | +9.4% | -8.3% |
| EDIT | SELL | 2018-01-02 | 2018-01-04 | $34.20 | $1.0M | -11.2% | -0.6% | -1.2% |
| EDIT | SELL | 2017-12-01 | 2017-12-05 | $29.70 | $400K | -2.6% | +32.1% | +49.9% |
| EDIT | SELL | 2017-11-01 | 2017-11-03 | $23.52 | $340K | -5.2% | +8.1% | +42.4% |
| EDIT | SELL | 2017-10-02 | 2017-10-04 | $24.78 | $408K | -4.2% | +4.7% | +44.2% |
| EDIT | SELL | 2017-09-01 | 2017-09-06 | $20.29 | $473K | +7.5% | +25.8% | +37.3% |
| EDIT | SELL | 2017-08-10 | 2017-08-14 | $20.02 | $467K | -15.7% | -8.9% | +6.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.